20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T11418 | Glucokinase activator 1 | Others | |
Glucokinase activator 1 is a liver-directed glucokinase activator (EC50: 34 nM). | |||
T72284 | Glucokinase activator 3 | ||
Glucokinase Activator 3, a highly potent and complete activator of Glucokinase (GK), exhibits an AC50 value of 38 nM. This compound holds potential for type 2 diabetes research applications. | |||
TQ0055 | AMG-3969 | Glucokinase | |
AMG-3969 is an effective glucokinase-glucokinase regulatory protein interaction (GK-GKRP) disruptor (IC50: 4 nM). | |||
T16479 | PF-04937319 | Others , Glucokinase | |
PF-04937319 is an activator of glucokinase (EC50 =154.4 μM). PF-04937319 maintains glucose-lowering efficacy while mitigating the risk of hypoglycemia observed with many other glucokinase activators. PF-04937319 can be ... | |||
T3312 | AM-2394 | AM2394 | Glucokinase |
AM-2394 is an effective and specific Glucokinase agonist (GKA, EC50: 60 nM), which catalyzes the phosphorylation of glucose to glucose-6-phosphate. AM-2394(AM2394) increases the affinity of GK for glucose by approximatel... | |||
T3104 | Globalagliatin | LY2608204 | Glucokinase |
Globalagliatin (LY2608204) has been used in trials studying the treatment of Diabetes Mellitus, Type 2. | |||
T26712 | AZD-1656 | AZD 1656 | Glucokinase |
AZD-1656 is a glucokinase activator (GKA) that can cause dose-limiting hypoglycemia in normal animals used in embryofetal development studies and type 2 diabetes. | |||
T15159 | Dorzagliatin | HMS5552 | Glucokinase |
Dorzagliatin (HMS5552) is a dual-acting glucokinase (GK) activator. It also improves glycaemic control and pancreatic β-cell function in type 2 diabetes. | |||
T12056 | MK-0941 free base | Glucokinase | |
MK-0941 free base is an orally active glucokinase activator, exhibiting strong glucose-lowering activity and is a potential therapeutic agent for treatment of type 2 diabetes. | |||
T19500 | Palmitelaidic Acid | trans-Palmitoleic acid,9-trans-Hexadecenoic acid | Glucokinase , AMPK , PPAR |
Palmitelaidic Acid (trans-Palmitoleic acid) is one of the most abundant fatty acids in serum and tissue. | |||
T68762 | LY-2599506 | ||
LY-2599506 is a novel glucokinase activator. | |||
T30142 | ARRY-403 | AMG-151,ARRY 403,ARRY403,ARRY-403,AMG151,AMG 151 | Glucokinase |
ARRY-403 is a novel glucokinase activator that reduces fasting and postprandial blood glucose in patients with type 2 diabetes. | |||
T77784 | WAY-297848 | Glucokinase | |
WAY-297848 is a novel glucokinase activator for the prevention or treatment of hyperglycemia, diabetes mellitus, obesity, dyslipidemia, and metabolic syndrome. | |||
T3104L | (1S,2R)-Globalagliatin | (1S,2R)-Globalagliatin(1S,2R-1234703-40-2) | Glucokinase |
(1S,2R)-Globalagliatin is a highly potent glucokinase (GK) activator for the study of type 2 diabetes. | |||
T14212 | AMG-1694 | Glucokinase | |
AMG-1694, a potent disruptor of the glucokinase–glucokinase regulatory protein (GK-GKRP) complex, operates by promoting the dissociation of this complex, thereby indirectly enhancing GK enzymatic activity with an IC50 of... | |||
T4726 | D-Glucose 6-phosphate sodium | G6P sodium salt,D-Glucose 6-phosphate sodium salt,Sodium Glucose-6-Phosphate | Others , Endogenous Metabolite |
In cells, D-glucose 6-phosphate (G6P) is generated when glucose is phosphorylated by hexokinase or glucokinase or by the conversion of glucose-1-phosphate by phosphoglucomutase during glycogenolysis. G6P lies at the begi... | |||
T23765 | AZD1092 | AZD 1092,AZD-1092 | |
AZD1092 is the glucokinase enzyme activator. | |||
T25452 | GKA-71 | GKA 71 | |
GKA-71 is an effective glucokinase activator (GKA). | |||
T64046 | BMS-820132 | ||
BMS-820132 is a glucokinase activator (AC50: 29 nM). | |||
T5069 | D-Glucose 6-phosphate potassium salt | Others | |
D-Glucose 6-phosphate potassium is the potassiu salt form of D-glucose 6-phosphate, which is a glucose sugar phosphorylated at the hydroxy group on carbon 6. |